Topical erythromycin for acne vulgaris

Area of Science:

• Dermatology
• Microbiology

Background:

• Acne vulgaris is a common skin condition.
• Topical antibiotics are used for acne treatment.
• Propionibacterium acnes is implicated in acne pathogenesis.

Purpose of the Study:

• To evaluate the clinical efficacy of 1% topical erythromycin in a novel penetrative vehicle for acne vulgaris.
• To compare the new formulation against a placebo in a double-blind study.

Main Methods:

• A double-blind clinical trial was conducted.
• Twenty-eight patients with moderate to severe acne vulgaris participated.
• Treatment efficacy was assessed by comparing topical erythromycin with a placebo vehicle.

Main Results:

• The erythromycin preparation showed superior results in 21 out of 28 patients.
• The placebo was more effective in 4 patients, and no difference was observed in 3.
• Topical erythromycin in the penetrative vehicle demonstrated significant efficacy.

Conclusions:

• Topical erythromycin formulated in a new penetrative vehicle is a potent agent for treating acne vulgaris.
• The risk of developing resistant Propionibacterium acnes strains is a critical consideration for both topical and systemic antibiotic therapies for acne.